pillbase.ru

Leqembi

Active substance: lecanemab

Lecanemab

Centralised EU authorisationActive

Marketing holder: Eisai GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • LEQEMBI
    INJECTION, SOLUTION · LECANEMAB 100 mg/mL
    62856-212
    Eisai Inc.
  • LEQEMBI
    INJECTION, SOLUTION · LECANEMAB 100 mg/mL
    62856-215
    Eisai Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12096-ada4-78f7-a718-65741f9575d4,01a12098-f912-742e-98e1-5d4480ce29f9;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005966
Registration status
Active
ATC code
N06DX04
Sources
  • product · EMA · EMEA/H/C/005966 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005966 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005966 · Verified 2026-10-09